Study to Assess Safety and Tolerability of KarXT With Administration of Antiemetics in Healthy Volunteers (clinicaltrials.gov) - Sep 19, 2026 - P4 | N=225 | Recruiting | Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company | Not yet recruiting ➔ Recruiting
Enrollment open
|